Immunohistochemistry Utilization in Medicare Beneficiaries by Mohs Surgeons From 2012-2017.
J Drugs Dermatol
; 20(8): 905-906, 2021 Aug 01.
Article
em En
| MEDLINE
| ID: mdl-34397191
ABSTRACT
Based on surveys by Robinson1 in 2001 and Trimble and Cherpeli2 in 2013, Immunohistochemistry (IHC) utilization in Mohs micrographic surgery (MMS) has been rising. Although these surveys provided important subjective data regarding IHC use in MMS, there is a paucity of objective data describing its current utilization patterns. The objective of this study is to characterize IHC utilization during MMS by Mohs surgeons in the treatment of Medicare beneficiaries from 2012-2017.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Cirurgiões
Limite:
Aged
/
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
J Drugs Dermatol
Assunto da revista:
DERMATOLOGIA
Ano de publicação:
2021
Tipo de documento:
Article